State Of Alaska, Department Of Revenue Supernus Pharmaceuticals, Inc. Transaction History
State Of Alaska, Department Of Revenue
- $9.79 Billion
- Q3 2025
A detailed history of State Of Alaska, Department Of Revenue transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 31,160 shares of SUPN stock, worth $1.61 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
31,160
Previous 33,314
6.47%
Holding current value
$1.61 Million
Previous $1.05 Million
41.85%
% of portfolio
0.02%
Previous 0.01%
Shares
33 transactions
Others Institutions Holding SUPN
# of Institutions
318Shares Held
60.9MCall Options Held
18.4KPut Options Held
0-
Black Rock Inc. New York, NY10.4MShares$536 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.21MShares$320 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.81MShares$248 Million2.66% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.02MShares$156 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.76MShares$142 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $2.76B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...